Bayer Pharmaceuticals strengthens the pharmaceutical production network in the Asia-Pacific Region to reach those who are most in need. CONTRIBUTED PHOTO
FOUR major launches of innovative treatments Finerenone, Vericiguat, Larotrectinib and Darolutamide underscore Bayer's commitment to reducing the burden of cardiovascular diseases and cancer in the APAC region.